← FDA Drug Approvals (Drugs@FDA)
LETROZOLE;VRIBOCICLIB SUCCINATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN LABS PVT LTD · Approved 2023-05-01
Drug application
- FDA Application #
ANDA215975- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LETROZOLE;VRIBOCICLIB SUCCINATE
- Generic name
- Letrozole
- Active ingredients
- LETROZOLE; RIBOCICLIB SUCCINATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MSN LABS PVT LTD
- First approval
- 2023-05-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown